abstract |
The present invention is a novel stable compressed vaccine composition comprising at least one anhydrous antigen component, comprising an effervescent stabilizer when the composition is mixed with a liquid diluent, and an effective amount of a sugar alcohol Related to things. [Selection] Figure 1 |